Monday, September 28, 2020
- Advertisement -
Speed up your site performance today, Free site transfer, same renewal price

APPLICATIONS

Biopharma has abandoned antibiotic development. Here’s why we did, too.

Tim­ing is Every­thing When we launched Oc­ta­gon Ther­a­peu­tics in late 2017, I was con­vinced that the time was right for a new an­tibi­ot­ic dis­cov­ery ven­ture. The com­pa­ny was found­ed on im­pres­sive aca­d­e­m­ic pedi­gree and the man­age­ment team had known each oth­er for years. Our first pro­gram was based on a com­pelling ap­proach to tar­get­ing cen­tral…

HOT NEWS

Skip to toolbar